Fair Pay & Worker Respect

The CEO's total compensation of US$4.44 million as of December 31, 2024, compared to the median employee total compensation of $132,300 per year, results in a CEO-to-median employee pay ratio of approximately 33.56:1.

Employee engagement is low, with an overall rating of 2.6 out of 5 stars on Glassdoor, and only 25% of employees would recommend working at the company. The company has experienced frequent layoffs, with approximately 12% of its workforce terminated in Q1 2023 and another 16% in September 2023, and reviews mention 3 layoffs within about 2 years. QSI provides a comprehensive benefits package, including medical, dental, and vision healthcare coverage, life insurance, disability coverage, 401(k) investment plans, and employee assistance programs, indicating approximately 100% health insurance coverage for employees.

Kind to Animals

The company conducts animal testing for medical analysis and clinical research.

However, no explicit animal testing policy is stated in the provided documents. While the company offers a 24-Plex Barcoding Kit that can reduce animal use by up to 87% in mouse studies and up to 95% in NHP models, this is a product feature for reducing animal use within testing, not a non-animal alternative, and no actual animal testing volume is disclosed.

No War, No Weapons

No specific evidence was found regarding Quantum-Si Incorporated's (QSI.US) involvement in arms manufacturing, military contracts, or conflict facilitation. While one article mentions a contract for QSI.US with the Department of the Navy, Naval Research Laboratory, valued at up to $170,500,

the company's total revenue is not provided, making it impossible to determine the percentage of revenue derived from this contract. General discussions about the dual-use potential of quantum technologies and new export controls do not provide specific data on QSI.US's R&D investment, sales to embargoed regimes, or any peacebuilding initiatives. An article discussing conflict minerals refers to 'Quantum Corporation', which is a different entity and therefore not applicable to QSI.US. Consequently, no KPIs could be scored based on the provided information.

Planet-Friendly Business

The company has no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided articles.

However, there is no publicly available carbon emissions data, specific reduction targets, or climate commitments. The company is also not participating in any tracked reduction initiatives. Information regarding renewable energy, water use, green building certifications, waste diversion, capital expenditure alignment with EU taxonomy, lifecycle impact analysis, recycled material usage, carbon offsets, climate-positive initiatives, supply chain climate transparency, supplier SBTi targets, biodiversity efforts, deforestation policies, environmental impact assessments, net-zero targets, TCFD alignment, climate scenario analysis, stranded assets, water from stressed basins, packaging CO2 reduction, climate justice, just transition, or climate adaptation financing is not available.

Respect for Cultures & Communities

The provided article focuses exclusively on Quantum-Si's protein sequencing technology and its applications in drug development.

It does not contain any information, quantitative data, or specific details regarding the company's social responsibility, community engagement, cultural sensitivity, or any other metrics relevant to the 'Respect for Cultures & Communities' ethical value. Therefore, no KPIs can be scored based on the evidence provided.

Safe & Smart Tech

Quantum-Si has not experienced any documented data breaches involving data compromise.

A ransomware incident occurred in August 2020, but no employee data or personal information was accessed. The company maintains a cybersecurity program based on NIST frameworks and industry standards, which includes security monitoring, audits, vulnerability assessments, penetration testing, employee training, and an incident response plan. The Audit Committee of the Board of Directors provides oversight of cybersecurity risk management. The company uses data anonymization and encryption to protect personal information, though email inquiries are noted as not encrypted unless a user has an encryption service. Contracts with data processors restrict their access to and use of personal information. Users have rights to access, correct, restrict, or remove their personal information, and erasure requests are actioned within 30 days. California residents can opt-out of the sale of their personal information and request information about third-party data sharing once a year, free of charge. The company states it complies with GDPR for users in the European Economic Area, the United Kingdom, and Switzerland, and with California privacy laws.

Zero Waste & Sustainable Products

The company utilizes third-party vendors for the disposal of regulated medical waste, hazardous waste, and radioactive materials.

No information is provided regarding waste disposal violations, regulatory actions, fines, or compliance issues. For all other KPIs, including waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, product durability, repairability, waste audit frequency, zero waste certifications, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, and customer waste education, no specific data is available.